Dr. Courtney Houston, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 621 E Main Street, Charleston, AR 72933 Phone: 479-965-2244 Fax: 479-965-2023 |
News Archive
Cancer Research UK's Drug Development Office has launched a clinical trial* to test an experimental drug in patients with advanced (Stage IV) pancreatic cancer - one of the most difficult cancers to treat.
ThromboGenics NV, a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, announces that further data from the first successful Phase III trial with microplasmin (TG-MV-006) for the non-surgical treatment of vitreomacular adhesion (VMA) were presented at the World Ophthalmology Congress by Dr. Matthew Benz, MD (The Methodist Hospital, Houston, Texas, U.S.)
Plastics surround us. A vital manufacturing ingredient for nearly every existing industry, these materials appear in a high percentage of the products we use every day. Although modern life would be hard to imagine without this versatile chemistry, products composed of plastics also have a dark side, due in part to the very characteristics that make them so desirable-their durability and longevity.
According to an announcement from the Food and Drug Administration (FDA) on Monday, it has approved the new flu vaccine for the season beginning this year. Each year the FDA works with other federal agencies and global health experts to design a vaccine to protect against the three viral strains most likely to cause the flu.
In 1962, St. Jude Children's Research Hospital opened its doors amid an emotionally charged debate regarding how to treat childhood cancer. At that time, few children with the most common form of childhood cancer survived, and many physicians believed treatment was futile. St. Jude physicians and researchers took a radically different approach, and these efforts proved pivotal in changing the way the world treats childhood cancer.
› Verified 7 days ago